Stranger than fiction.

The sports car maker wants to shield its fellow German automaker from potential takeover bids.

The subprime mess trips up people with better credit, Microsoft has a bad week and much more.

Bank of America bonuses, Costco’s options, Starbuck’s music label and much, much more.

A phase I study suggests that adult stem cells might have a future as a heart-repairing therapy.

The highlights from our bloggers: Rev Shark, Cody Willard, Steve Smith and Tony Crescenzi.

The best CEOs, plus how to tell whether litigation is good for a company.

Investors benefit from new rules requiring firms to reveal all kinds of executive perks.

The positive performance of the Xience stent in a key study should help pave the way for FDA approval.